Is Genprex Inc halal to invest in?

As of July 2026, Genprex Inc 2DE0.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Genprex Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Genprex Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Genprex Inc?

Muslim investors may consider investing in Genprex Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Genprex Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Genprex Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Genprex Inc updated?

The Shariah compliance status of Genprex Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Genprex Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Genprex Inc?

You can check the latest Shariah compliance status of Genprex Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Genprex Inc 2DE0.BE

Last Updated: Feb 01, 12:00 AM·BE

2DE0.BE Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Genprex Inc is classified as not halal.

NOT HALAL

Report Source: 2026 1st Quarter Report

Genprex Inc. Stock Analysis 2DE0.BE

Germany Health Care Nano Cap Report: Q1, 2026

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company is headquartered in Austin, Texas and currently employs 15 full-time employees. The company went IPO on 2018-03-29. The firm's technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes, who have limited treatment options. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which uses lipid-based nanoparticles in a lipoplex form to deliver tumor suppressor gene-expressing plasmids to cancer cells. Its oncology drug candidate, Reqorsa Gene Therapy (quaratusugene ozeplasmid), is developed in combination with approved cancer drugs to treat Non-Small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC). GPX-002 is being developed by the Company using the same construct for the treatment of both Type 1 diabetes and Type 2 diabetes. GPX-002 for Type 1 diabetes is designed to work by transforming alpha cells in the pancreas into functional beta-like cells.

Key Statistics of Genprex Inc (2DE0.BE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€6.79€7.50

Today's Open

€7.15

Volume

400.00

P/E Ratio (TTM)

Financial Metrics & Statements of Genprex Inc (2DE0.BE)

Super Investors Invested in Genprex Inc (2DE0.BE)

FAQ's for Genprex Inc (2DE0.BE)

As of July 2026, Genprex Inc 2DE0.BE is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Genprex Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Genprex Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Genprex Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Genprex Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Genprex Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.